A
Annalisa Mondi
Researcher at The Catholic University of America
Publications - 63
Citations - 1253
Annalisa Mondi is an academic researcher from The Catholic University of America. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 40 publications receiving 791 citations. Previous affiliations of Annalisa Mondi include Catholic University of the Sacred Heart.
Papers
More filters
Journal ArticleDOI
National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management.
Emanuele Nicastri,Nicola Petrosillo,Tommaso Ascoli Bartoli,Luciana Lepore,Annalisa Mondi,Fabrizio Palmieri,Gianpiero D'Offizi,Luisa Marchioni,Silvia Murachelli,Giuseppe Ippolito,Andrea Antinori +10 more
TL;DR: Recommendations for the management of COVID-19 patients are shown, based on very limited clinical evidences, which should be considered as expert opinions, which may be modified according to newly produced literature data.
Journal ArticleDOI
Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
Daniele Lapa,Fabrizio Carletti,V Mazzotta,Giulia Matusali,Carmela Pinnetti,Silvia Meschi,Roberta Gagliardini,Francesca Colavita,Annalisa Mondi,Claudia Minosse,Laura Scorzolini,Stefania Cicalini,Gaetano Maffongelli,Eliana Specchiarello,Marta Camici,Aurora Bettini,Francesco Baldini,Massimo Francalancia,K. Mizzoni,Anna Rosa Garbuglia,Emanuele Nicastri,Enrico Girardi,Andrea Antinori,Francesco Vaia,Fabrizio Maggi +24 more
TL;DR: A cross-sectional serosurvey of antiorthopoxvirus antibodies in central and western Africa and the effectiveness of postexposure vaccination for the prevention of smallpox: results of a Delphi analysis.
Journal ArticleDOI
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
Mattia Prosperi,Mattia Prosperi,Massimiliano Fabbiani,Iuri Fanti,Mauro Zaccarelli,Manuela Colafigli,Annalisa Mondi,Alessandro D'Avino,Alberto Borghetti,Roberto Cauda,Simona Di Giambenedetto +10 more
TL;DR: After starting antiretroviral therapy, the probability of remaining free from adverse events seems to decrease over time and older age, CDC stage, MSM risk factor and gender are also associated with an increased hazard of toxicity and should be considered when designing a first-line regimen.
Journal ArticleDOI
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
Simona Di Giambenedetto,Massimiliano Fabbiani,Eugenia Quiros Roldan,Alessandra Latini,Gabriella d'Ettorre,Andrea Antinori,Antonella Castagna,Giancarlo Orofino,Daniela Francisci,Pierangelo Chinello,Giordano Madeddu,Pierfrancesco Grima,Stefano Rusconi,Massimo Di Pietro,Annalisa Mondi,Nicoletta Ciccarelli,Alberto Borghetti,Emanuele Focà,Manuela Colafigli,Andrea De Luca,Roberto Cauda +20 more
TL;DR: Treatment simplification to atazanavir/ritonavir’s+ lamivudine showed non-inferior efficacy (superiority on post-hoc analysis) and a comparable safety profile over continuing atazAnavir/.
Journal ArticleDOI
Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons
Margalida Rotger,Tracy R. Glass,Thomas Junier,Thomas Junier,Jens D Lundgren,James D. Neaton,Estella S. Poloni,Angélique B. van 't Wout,Rubin Lubomirov,Sara Colombo,Raquel Martinez,Andri Rauch,Huldrych F. Günthard,Jacqueline Neuhaus,Deborah Wentworth,Daniëlle van Manen,Luuk Gras,Hanneke Schuitemaker,Laura Albini,Carlo Torti,Carlo Torti,Lisa P. Jacobson,Xiuhong Li,Lawrence A. Kingsley,Federica Carli,Giovanni Guaraldi,Emily S Ford,Irini Sereti,Colleen Hadigan,Esteban Martínez,Mireia Arnedo,Lander Egaña-Gorroño,José M. Gatell,Matthew Law,Courtney Bendall,Kathy Petoumenos,Jürgen K. Rockstroh,Jan Christian Wasmuth,Kabeya Kabamba,Marc Delforge,Stéphane De Wit,Florian Berger,Stefan Mauss,Mariana De Paz Sierra,Marcelo H. Losso,Waldo H. Belloso,Maria Leyes,Antoni A Campins,Annalisa Mondi,Andrea De Luca,Ignacio Bernardino,Mónica Barriuso-Iglesias,Ana Torrecilla-Rodriguez,Juan González-García,Jose R. Arribas,Iuri Fanti,Silvia Gel,Jordi Puig,Eugenia Negredo,Mar Gutierrez,Pere Domingo,Julia Fischer,Gerd Fätkenheuer,Carlos Alonso-Villaverde,Alan Macken,James Woo,Tara McGinty,Patrick W. G. Mallon,Alexandra Mangili,Sally Skinner,Christine Wanke,Peter Reiss,Rainer Weber,Heiner C. Bucher,Jacques Fellay,Jacques Fellay,Amalio Telenti,Philip E. Tarr +77 more
TL;DR: In the setting of HIV infection, the effect of an unfavorable genetic background was similar to traditional CAD risk factors and certain adverse antiretroviral exposures and genetic testing may provide prognostic information complementary to family history of CAD.